Welcome: Guest | Site Use Options | Register | Login |

Aarden Pharmaceuticals Inc

Profile last edited on: 6/26/19
351 West 10th Street Suite 505
Indianapolis, IN 46202
  (317) 690-2453
  N/A
  www.aardenpharma.com
Business Identifier: Drugs targeting phosphatase family of proteins: emphasis on protein tyrosine phosphatases
Public Profile:
Aarden had been a small molecule drug discovery and development company. working with novel technology licensed from the labs of the Indiana University School of Medicine. The technology represented a chemistry breakthrough that could enable the firm to make drugs against a previously undruggable set of intracellular phosphatase (PTP) disease targets. Targeting the phosphatase family of proteins with emphasis on protein tyrosine phosphatases that catalyze the removal of phosphate groups from tyrosine residues of proteins and play key roles along with the tyrosine kinases in various signal transduction pathways, Arden Pharmaceuticals, Inc.'s drug program focus was on infectious diseases, cancer, metabolic, and autoimmune therapeutic areas. Record seems to suggest that firm ceased operation in/around 2013

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Inhibitors of Mycobacterial Protein Tyrosine Phosphatase B (Mptpb) for Therapy Of

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com